Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Fast track status for pixantrone in aggressive NHL

July 14, 2004

Adherex Technologies updates status of two key programs

July 14, 2004

Cytorex Biosciences completes cytotoxicity testing with Cytoreg

July 14, 2004

Inhibitors of receptor tyrosine kinases claimed by Array BioPharma

July 13, 2004

Novel insulin-like growth factor-I receptor kinase inhibitors against tumor growth

July 13, 2004

Enrollment begins in phase II Xcytrin study for metastatic renal cell carcinoma

July 13, 2004

Abbott plans Xinlay NDA filing later this year

July 13, 2004

Antagonists of antiapoptotic protein for the treatment of cancer

July 12, 2004

Bayer describes agents for hyperproliferative disorders

July 12, 2004

Silicon compounds for GnRH related disorders

July 12, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...